Physician

Melike Arslan, M.D.

According to 2025 Medicare claims, Melike Arslan, M.D. (NPI: 1043337439) practices interventional cardiology in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is FRANCISCAN MEDICAL GROUP (NPI: 1366539421; TIN: 911939739) and primary practice location at 98383-7663. Arslan is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and Jefferson Accountable Care, LLC (ACO ID: A5275), participating under the MSSP model.

Arslan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,838 traditional Medicare patients, billed 4,466 HCPCS/CPT codes, and received $284,460 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,087 prescription claims across 556 beneficiaries totaling $1,055,078 in drug costs, led by Entresto (Sacubitril/Valsartan). Open Payments data shows 13 records totaling $268. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $83,843 to $1,055,078. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,098	2,117	$127,036
2016	1,495	4,303	$300,812
2017	1,603	4,890	$333,415
2018	2,434	6,288	$388,063
2019	2,352	6,656	$395,141
2020	2,008	5,074	$311,627
2021	2,014	5,277	$340,219
2022	1,889	4,893	$318,885
2023	1,970	4,528	$269,840
2024	1,838	4,466	$284,460

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	220	2,037	$83,843
2016	187	1,264	$81,717
2017	207	1,569	$118,610
2018	259	1,691	$129,755
2019	320	2,109	$186,875
2020	346	2,534	$282,701
2021	352	2,543	$389,072
2022	388	2,835	$482,313
2023	432	3,240	$749,871
2024	556	4,087	$1,055,078

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	454	587	$90
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	520	531	$87
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	192	196	$10
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	253	273	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	496	674	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	171	10,814	$223,523
Eliquis	Apixaban	126	8,055	$157,337
Xarelto	Rivaroxaban	112	8,446	$153,336
Jardiance	Empagliflozin	98	7,040	$126,316
Repatha Sureclick	Evolocumab	61	3,500	$67,230

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$268	ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Melike Arslan, M.D.?

Tedicare shows public-source Medicare data for Melike Arslan, M.D. (NPI 1043337439), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Melike Arslan, M.D. have ACO affiliation data?

Melike Arslan, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and Jefferson Accountable Care, LLC (MSSP, ACO ID A5275).

What billing organization is linked to Melike Arslan, M.D.?

Melike Arslan, M.D. is linked to FRANCISCAN MEDICAL GROUP (billing NPI 1366539421) in the available physician profile data.

Does Melike Arslan, M.D. have Open Payments data?

Melike Arslan, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.